| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 646 companies in the Biotechnology industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | MLYS Mineralys Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 7,438 | $26.87 | $199,885.09 | -16.2% | - | - | |
| Jul 21, 2026 | MGTX Meiragtx Holdings Plc | Giroux Richard64 | CFO &COO | Sell | 56,000 | $12.51 | $700,560.00 | -5.8% | - | - | |
| Jul 21, 2026 | RANI Rani Therapeutics Holdings, Inc. | Imran Mir A | Director, 10% Owner | Buy | 36,000 | $0.69 | $24,840.00 | +1.7% | - | - | |
| Jul 21, 2026 | CYTK Cytokinetics, Incorporated | Malik Fady Ibraham54 | EVP Research &Development | Sell | 3,500 | $80.59 | $282,065.00 | -2.2% | - | - | |
| Jul 21, 2026 | BEIGF Beone Medicines AG | Oyler John59 | Chief Executive Officer | Sell | 109,713 | $315.28 | $34,590,855.40 | -45.6% | - | - | |
| Jul 21, 2026 | BOLD Boundless Bio, Inc. | Tang Kevin85 | 10% Owner | Buy | 4,863 | $2.44 | $11,865.72 | - | - | - | |
| Jul 20, 2026 | SGMT Sagimet Biosciences Inc. | Kemble George | Director | Sell | 18,844 | $7.46 | $140,529.13 | -23.3% | - | - | |
| Jul 20, 2026 | ANIX Anixa Biosciences, Inc. | Kumar Amit62 | Chief Executive Officer | Buy | 5,000 | $3.46 | $17,300.00 | +0.8% | - | - | |
| Jul 20, 2026 | MLTX Moonlake Immunotherapeutics | Reich Kristian78 | Chief Scientific Officer | Sell | 43,700 | $20.09 | $877,933.00 | -1.6% | - | - | |
| Jul 20, 2026 | SGMT Sagimet Biosciences Inc. | Rozek Elizabeth | Chief Legal &Admin. Officer | Sell | 10,545 | $7.76 | $81,832.36 | -4.5% | - | - | |
| Jul 20, 2026 | AKTS Aktis Oncology, Inc. | Herrmann Ken | Director | Sell | 4,856 | $24.56 | $119,274.04 | -78.2% | - | - | |
| Jul 20, 2026 | ANIX Anixa Biosciences, Inc. | Titterton Lewis H Jr65 | Director | Buy | 12,000 | $3.47 | $41,640.00 | +1.2% | - | - | |
| Jul 20, 2026 | SGMT Sagimet Biosciences Inc. | Happel David71 | President &CEO | Sell | 64,051 | $7.76 | $497,067.79 | -8.0% | - | - | |
| Jul 20, 2026 | IMNN Imunon, Inc. | Eylward Susan | General Counsel And Corp Sec | Sell | 2,150 | $1.78 | $3,830.44 | -42.6% | - | - | |
| Jul 20, 2026 | MDGL Madrigal Pharmaceuticals, Inc. | Sibold William John | President And CEO | Sell | 2,500 | $547.30 | $1,368,253.45 | -0.1% | - | - | |
| Jul 20, 2026 | GDTC Cytomed Therapeutics Limited | Choo Chee Kong | Director, 10% Owner | Buy | 200,000 | $1.50 | $300,000.00 | +20.8% | - | - | |
| Jul 20, 2026 | GDTC Cytomed Therapeutics Limited | Choo Chee Kong | Director, 10% Owner | Buy | 200,000 | $1.50 | $300,000.00 | +20.8% | - | - | |
| Jul 17, 2026 | BEIGF Beone Medicines AG | Oyler John59 | Chief Executive Officer | Sell | 64,628 | $312.00 | $20,163,906.53 | -17.1% | - | - | |
| Jul 17, 2026 | PRQR Proqr Therapeutics N.V. | Filius Bart | Director | Buy | 150,000 | $1.72 | $257,925.00 | +100.0% | - | - | |
| Jul 17, 2026 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom54 | Chief Medical Officer | Sell | 416 | $26.53 | $11,036.48 | -0.8% | - | - | |
| Jul 17, 2026 | RANI Rani Therapeutics Holdings, Inc. | Imran Talat53 | Chief Executive Officer | Buy | 35,000 | $0.72 | $25,193.00 | +8.1% | - | - | |
| Jul 17, 2026 | ELVN Enliven Therapeutics, Inc. | Hohl Benjamin59 | Chief Financial Officer | Sell | 6,018 | $52.64 | $316,780.33 | -2.4% | - | - | |
| Jul 17, 2026 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | Sell | 10 | $13.70 | $137.00 | - | - | - | |
| Jul 17, 2026 | AKTS Aktis Oncology, Inc. | Herrmann Ken | Director | Sell | 3,065 | $25.21 | $77,258.54 | -100% | - | - | |
| Jul 17, 2026 | BCDA Biocardia, Inc. | Altman Peter46 | President And CEO | Buy | 500 | $0.83 | $415.00 | +0.1% | - | - |